Trial Profile
Letrozole in the treatment of severe and recurrent endometriosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Gonadotropin releasing hormone stimulants
- Indications Endometriosis
- Focus Therapeutic Use
- 25 Apr 2012 Actual end date (June 2006) added as reported by ClinicalTrials.gov.
- 05 Jul 2007 Status changed from in progress to completed.
- 10 Dec 2005 New trial record.